Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Income Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Revenue	31.75	31.99	31.34	30.34	28.88	31.15
Revenue Growth (YoY)	-0.29%	2.05%	3.32%	5.03%	-7.26%	-2.10%
Cost of Revenue	7.28	7.95	12.13	8.79	10.15	10.94
Gross Profit	24.47	24.04	19.22	21.54	18.73	20.21
Selling, General & Admin	18.79	18.52	17.17	15.58	14.61	14.29
Research & Development	0.6	1.24	1.17	0.38	0.05	0.02
Operating Expenses	20.15	20.25	19.46	17.08	15.49	14.48
Operating Income	4.32	3.79	-0.25	4.46	3.24	5.72
Interest Expense	-2.33	-1.86	-1.24	-1.08	-1.38	-1.54
Interest & Investment Income	-	0.11	0.12	-	-	-
Other Non Operating Income (Expenses)	0.04	0.01	0	0	0	0
EBT Excluding Unusual Items	2.03	2.04	-1.36	3.39	1.86	4.18
Gain (Loss) on Sale of Investments	-0.58	0.77	0.05	-0.04	-0.01	-0.01
Gain (Loss) on Sale of Assets	-	-	-	0.41	-0.02	-
Asset Writedown	-	-	-13.11	-	-	-
Other Unusual Items	0.01	-0	1.05	-0.44	0.78	0.87
Pretax Income	1.45	2.8	-13.36	3.32	2.61	5.04
Income Tax Expense	1.93	2.4	-3.84	0.55	0.53	1.41
Net Income	-0.47	0.4	-9.52	2.77	2.08	3.62
Net Income to Common	-0.47	0.4	-9.52	2.77	2.08	3.62
Net Income Growth	-	-	-	33.02%	-42.52%	58.23%
Shares Outstanding (Basic)	8	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change (YoY)	-1.40%	-1.54%	-1.69%	1.46%	2.72%	-3.24%
EPS (Basic)	-0.06	0.05	-1.14	0.33	0.26	0.48
EPS (Diluted)	-0.06	0.05	-1.14	0.33	0.25	0.45
EPS Growth	-	-	-	30.95%	-44.44%	66.67%
Free Cash Flow	6.18	3.61	2.08	-3.6	6.09	8.37
Free Cash Flow Per Share	0.77	0.44	0.25	-0.42	0.73	1.03
Dividend Per Share	0.250	0.250	-	-	-	-
Gross Margin	77.07%	75.15%	61.31%	71.02%	64.85%	64.87%
Operating Margin	13.60%	11.85%	-0.79%	14.70%	11.20%	18.37%
Profit Margin	-1.49%	1.26%	-30.38%	9.13%	7.21%	11.64%
Free Cash Flow Margin	19.48%	11.28%	6.64%	-11.85%	21.09%	26.86%
EBITDA	5.31	4.48	1.15	5.96	4.27	6.09
EBITDA Margin	16.72%	14.02%	3.68%	19.64%	14.80%	19.56%
D&A For EBITDA	0.99	0.69	1.4	1.5	1.04	0.37
EBIT	4.32	3.79	-0.25	4.46	3.24	5.72
EBIT Margin	13.60%	11.85%	-0.79%	14.70%	11.20%	18.37%
Effective Tax Rate	132.61%	85.66%	-	16.50%	20.21%	28.07%
Revenue as Reported	31.75	31.99	31.34	30.34	28.88	31.15
Advertising Expenses	-	1.07	0.95	0.76	0.84	0.85

Updated Oct 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q